Citation Tools
PDFCystic fibrosis
Original article
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation